The DOI matches its Crossref record.
Interaction of C-Reactive Protein with Lymphocytes and Monocytes: Complement-Dependent Adherence and Phagocytosis
Abstract
The serum constituent C-reactive protein (CRP), which activates the classical complement (C) pathway when rε-acting with its substrates, was examined for its ability to mediate reactions of opsonic adherence and phagocytosis. Erythrocytes coated with C-polysaccharide (CPS) and reacted with CRP (E. CPS-CRP) failed to adhere to B cells and displayed only minimal adherence to monocytes. However, upon the addition of absorbed C or purified C components these cells were found to possess the cleavage products C4b and C3b, which in turn resulted in attachment of these cells to both human B lymphocytes and peripheral blood monocytes. E. CPS-CRP treated with C in the absence of antibody were readily phagocytosized by glass-adherent human monocytes. The phagocytosis of E. CPS-CRP-C was not only mediated by CRP but also required the presence of CRP on the surface of the red cells. The extent of ingestion was proportional to the amount of CRP on the red cell intermediate and was reduced by blocking monocyte receptors with aggregated human γ-globulin (HGG) at concentrations which did not impair the uptake of other particles. The mediation by CRP of reactions of opsonic adherence and phagocytosis as outlined in these studies points to a significant role for CRP in reactions of host defense and inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Pepys, M. B., & Baltz, M. L. (1983) · Advances in Immunology · doi:10.1016/s0065-2776(08)60379-x · Cited by 1,272
Human C-reactive protein: expression, structure, and function
Volanakis, J. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00042-6 · Cited by 926
Zwaka, T. P., Hombach, V., & Torzewski, J. (2001) · Circulation · doi:10.1161/01.cir.103.9.1194 · Cited by 845
Function of C-reactive protein
Du Clos, T. W. (2000) · Annals of Medicine · doi:10.3109/07853890009011772 · Cited by 801
Role of Monocytes in Atherogenesis
ØSTERUD, B., & BJØRKLID, E. (2003) · Physiological Reviews · doi:10.1152/physrev.00005.2003 · Cited by 412
C-Reactive Protein: An Activator of Innate Immunity and a Modulator of Adaptive Immunity
Du Clos, T. W., & Mold, C. (2004) · Immunologic Research · doi:10.1385/ir:30:3:261 · Cited by 407
The Major Receptor for C-Reactive Protein on Leukocytes Is Fcγ Receptor II
Bharadwaj, D., Stein, M.-P., Volzer, M., Mold, C., & Clos, T. W. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.4.585 · Cited by 391
Osmand, A. P., Friedenson, B., Gewurz, H., Painter, R. H., Hofmann, T., & Shelton, E. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.2.739 · Cited by 372
Self-citationWright, S. D., Tobias, P. S., Ulevitch, R. J., & Ramos, R. A. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1231 · Cited by 354
Schultz, D. R., & Arnold, P. I. (1990) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(90)90055-k · Cited by 293
COMPLEMENT ACTIVATION BY C‐REACTIVE PROTEIN COMPLEXES*
Volanakis, J. E. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22140.x · Cited by 278
Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes
Alles, V., Bottazzi, B., Peri, G., Golay, J., Introna, M., & Mantovani, A. (1994) · Blood · doi:10.1182/blood.v84.10.3483.3483 · Cited by 261
The Development of Serum Amyloid P as a Possible Therapeutic
Pilling, D., & Gomer, R. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02328 · Cited by 92
Metadata
- Authors
- Mortensen, R. F., Osmand, A. P., Lint, T. F., & Gewurz, H.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1976-09-01
- Volume
- 117
- Issue
- 3
- Pages
- 774-781
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2106065835
- Cited by
- 161
- References
- 0
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.